Leveraged tokens package a managed leveraged strategy into tradable units. Their underlying exposure is often maintained through derivatives, while buyers trade the token rather than managing each underlying contract themselves. Products can target amplified upward or inverse exposure to an asset.
Rebalancing changes the exposure
The manager adjusts underlying positions to pursue the product's target leverage or permitted range. Reset schedules and additional triggers differ; daily rebalancing is not a universal rule. Actual leverage can change between adjustments.
A stated multiple is not a promise to multiply the asset's return over any holding period. Rebalancing and compounding make results depend on the price path. Repeated reversals can erode value even when the underlying finishes near its starting price, while sustained trends can produce different compounding effects.
Costs and risks remain inside the product
An outright token buyer generally does not post separate margin for the underlying strategy or receive its margin calls. That convenience does not make the investment safe: leveraged exposure can cause severe losses, and the strategy still depends on derivatives execution and the provider's management.
Management charges and underlying trading or funding costs affect returns according to product rules. The token's market price can also trade above or below its net asset value. Liquidity, redemption restrictions and delisting procedures matter when exiting; the product name alone does not describe these conditions.